3月13日 - ** 疫苗生产商莫德纳MRNA.O、NovavaxNVAX.O和辉瑞PFE.N的股票上涨，原因是白宫撤回了 (link)，提名疫苗批评家戴夫-韦尔登（Dave Weldon）担任美国疾病控制和预防中心主任。
** 莫德纳 MRNA.O上涨4.17%，至36.47美元；Novavax NVAX.O上涨1.85%，至8.25美元；辉瑞PFE.N小幅上涨。
** 这位前共和党国会议员原定于周四出席参议院卫生、教育、劳工和养老金委员会的确认听证会。
** 委员会确认撤回提名，并称听证会已取消
** 自特朗普当选连任，并选择著名的疫苗怀疑论者小罗伯特-肯尼迪（Robert F. Kennedy Jr）领导美国最高卫生机构--卫生与公众服务部以来，股市一直面临压力。
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.